Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal Cancer

NCT00575562 is registered in ClinicalTrials.gov with Kyowa Kirin, Inc. as lead sponsor.

NCT NCT00575562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00575562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal Cancer
Lead sponsor
Kyowa Kirin, Inc.
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2007
Completion date
January 31, 2010
Enrollment
42 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer